Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2014 Elsevier Inc. All rights reserved. Starting about 60 years ago, a number of reports appeared that outlined the severe clinical course of a few adult subjects with profound hypogammaglobulinemia. Puzzled by the lack of family history and adult onset of symptoms in most, the name "acquired" hypogammaglobulinemia was given, but later altered to the current name common variable immune deficiency (CVID). Pathology reports remarked on the loss of lymph node architecture and paucity of plasma cells in these subjects. While characterized by reduced serum IgG and IgA and often IgM, and thus classified among the B-cell defects, numbers of cellular defects have been recognized over time. In the past, severe respiratory tract infections commonly led to a shortened life span but the widespread availability of immune globulin concentrates for the last 25 years has dramatically lowered the morbidity and mortality noted in earlier reports.

Original publication





Book title

Primary Immunodeficiency Disorders: A Historic and Scientific Perspective

Publication Date



275 - 282